Clinical study to evaluate the safety and efficacy of a new targeted radioactive drug treatment for advanced prostate cancer

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 5
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult men with advanced prostate cancer that has spread. It tests a new targeted radioactive drug.

Age

18 years or older

Sex

Men only

Disease stage

Advanced prostate cancer that has spread (metastatic)

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details